MedPath

Effect rose essential on nausea and vomiting of chemotherapy

Not Applicable
Recruiting
Conditions
ausea and vomiting severity after chemotherapy.
Nausea and vomiting
Registration Number
IRCT20100921004787N7
Lead Sponsor
Rasht University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
66
Inclusion Criteria

Age over 18 years
Having the experience of at least one cycle of chemotherapy
The ability to understand and speak Persian
Prescribing chemotherapy drugs that are classified as severe in terms of nausea and vomiting.

Exclusion Criteria

The presence of hepatitis
Suffering from brain malignancies and other metastases
Allergy to herbal medicines and essential oils
Lack of sense of smell

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ausea and vomiting severity. Timepoint: Measuring the severity of nausea and vomiting once three hours before the intervention and then in three six-hour intervals after the intervention. Method of measurement: Visual Analogue Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath